By Matt Grossman

 

Danaher Thursday tweaked its full-year guidance to be more optimistic, forecasting that core sales growth will likely exceed 20% in 2021, rather than coming in at about that level.

The medical and diagnostics company said it expects base-business core sales to grow by more than 10% year over year in 2021, and that core sales growth will top 20% including the company's Covid-19 response activity.

Three months ago, Danaher was forecasting core sales growth would be about 20% for the year.

In the fourth quarter, core revenue growth will be in the low to mid teens year over year, Danaher forecast.

 

Write to Matt Grossman at matt.grossman@wsj.com

 

(END) Dow Jones Newswires

October 21, 2021 06:36 ET (10:36 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Danaher (NYSE:DHR)
Historical Stock Chart
From Oct 2021 to Nov 2021 Click Here for more Danaher Charts.
Danaher (NYSE:DHR)
Historical Stock Chart
From Nov 2020 to Nov 2021 Click Here for more Danaher Charts.